{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:35:30Z","timestamp":1787654130630,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.rpth.2026.103350","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T08:10:58Z","timestamp":1768291858000},"page":"103350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Direct oral anticoagulants in patients with advanced cirrhosis: is it time?"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9502-2434","authenticated-orcid":false,"given":"Eleonora","family":"Camilleri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3503-7140","authenticated-orcid":false,"given":"Ton","family":"Lisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2026.103350_bib1","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/jth.15239","article-title":"The concept of rebalanced hemostasis in patients with liver disease: communication from the ISTH SSC working group on hemostatic management of patients with liver disease","volume":"19","author":"Lisman","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.103350_bib2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1055\/s-0040-1718924","article-title":"Fibrinolysis in patients with liver disease","volume":"47","author":"von Meijenfeldt","year":"2021","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2026.103350_bib3","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1055\/s-0040-1715102","article-title":"Thrombin generation and cirrhosis: state of the art and perspectives","volume":"46","author":"Lebreton","year":"2020","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2026.103350_bib4","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000886","article-title":"Bleeding and thrombosis in patients with cirrhosis: what\u2019s new?","volume":"7","author":"Lisman","year":"2023","journal-title":"Hemasphere"},{"key":"10.1016\/j.rpth.2026.103350_bib5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/ajg.2008.34","article-title":"Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study","volume":"104","author":"S\u00f8gaard","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rpth.2026.103350_bib6","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1016\/j.jtha.2024.05.023","article-title":"Anticoagulation for stroke prevention in atrial fibrillation and treatment of venous thromboembolism and portal vein thrombosis in cirrhosis: guidance from the SSC of the ISTH","volume":"22","author":"Carlin","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.103350_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088390","article-title":"Differential in vitro inhibition of thrombin generation by anticoagulant drugs in plasma from patients with cirrhosis","volume":"9","author":"Potze","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2026.103350_bib8","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1182\/blood.2020005319","article-title":"Anticoagulant activity of edoxaban in patients with cirrhosis","volume":"136","author":"Bos","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.103350_bib9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jhep.2013.03.027","article-title":"Established and new-generation antithrombotic drugs in patients with cirrhosis\u2014possibilities and caveats","volume":"59","author":"Lisman","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.rpth.2026.103350_bib10","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/europace\/euab065","article-title":"2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"23","author":"Steffel","year":"2021","journal-title":"EP Europace"},{"issue":"Suppl 1","key":"10.1016\/j.rpth.2026.103350_bib11","article-title":"Safety and efficacy of direct oral anticoagulants in patients with liver cirrhosis: a meta-analysis","volume":"10","author":"Tham","year":"2026","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.103350_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jclinepi.2021.08.028","article-title":"Causal analyses of existing databases: no power calculations required","volume":"144","author":"Hern\u00e1n","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.rpth.2026.103350_bib13","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000001565","article-title":"Cirrhotic portal vein thrombosis as a vascular rather than a thrombotic disorder","author":"Huang","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.rpth.2026.103350_bib14","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.3390\/cancers17213413","article-title":"Thrombotic risk and coagulation imbalance in cirrhosis and hepatocellular carcinoma: clinical implications and management","volume":"17","author":"Stella","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.rpth.2026.103350_bib15","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1016\/j.jtha.2024.08.023","article-title":"Enhanced venous thrombosis and hypercoagulability in murine and human metabolic dysfunction-associated steatohepatitis","volume":"22","author":"Pandey","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.103350_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/jgh3.13074","article-title":"Safety of DOACs in patients with Child-Pugh class C cirrhosis and atrial fibrillation","volume":"8","author":"Ayoub","year":"2024","journal-title":"JGH Open"},{"key":"10.1016\/j.rpth.2026.103350_bib17","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1001\/jama.2022.21383","article-title":"Target trial emulation: a framework for causal inference from observational data","volume":"328","author":"Hern\u00e1n","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.rpth.2026.103350_bib18","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00228-024-03648-y","article-title":"Recommendations for the safe use of direct oral anticoagulants in patients with cirrhosis based on a systematic review of pharmacokinetic, pharmacodynamic and safety data","volume":"80","author":"Diesveld","year":"2024","journal-title":"Eur J Clin Pharmacology"},{"key":"10.1016\/j.rpth.2026.103350_bib19","article-title":"Comparison of apixaban, rivaroxaban, dabigatran, and vitamin K antagonists in patients with atrial fibrillation and liver disease: a network meta-analysis","volume":"16","author":"Shaikh","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.rpth.2026.103350_bib20","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jhep.2025.06.035","article-title":"Rivaroxaban to prevent complications of portal hypertension in cirrhosis: the CIRROXABAN study","volume":"83","author":"Puente","year":"2025","journal-title":"J Hepatol"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926000087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926000087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:55:32Z","timestamp":1778896532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037926000087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2475037926000087"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2026.103350","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct oral anticoagulants in patients with advanced cirrhosis: is it time?","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2026.103350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2025.103296","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"103350"}}